BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 19536023)

  • 1. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006.
    Greenberg D; Rosen AB; Wacht O; Palmer J; Neumann PJ
    Med Decis Making; 2010; 30(3):320-7. PubMed ID: 20228286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adoption of cost-effectiveness acceptability curves in cost-utility analyses.
    Meckley LM; Greenberg D; Cohen JT; Neumann PJ
    Med Decis Making; 2010; 30(3):314-9. PubMed ID: 19773582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analyses in gynecologic oncology: methodological quality and trends.
    Manuel MR; Chen LM; Caughey AB; Subak LL
    Gynecol Oncol; 2004 Apr; 93(1):1-8. PubMed ID: 15047206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved set of standards for finding cost for cost-effectiveness analysis.
    Barnett PG
    Med Care; 2009 Jul; 47(7 Suppl 1):S82-8. PubMed ID: 19536018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analyses in obstetrics & gynecology. Evaluation of methodologic quality and trends.
    Subak LL; Caughey AB; Washington AE
    J Reprod Med; 2002 Aug; 47(8):631-9. PubMed ID: 12216429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completing costs: patients' time.
    Russell LB
    Med Care; 2009 Jul; 47(7 Suppl 1):S89-93. PubMed ID: 19536025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
    Hoerger TJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
    Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
    Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of terminology and methodology in economic analyses in otolaryngology.
    Kezirian EJ; Yueh B
    Otolaryngol Head Neck Surg; 2001 May; 124(5):496-502. PubMed ID: 11337651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of the National truth campaign to prevent youth smoking.
    Holtgrave DR; Wunderink KA; Vallone DM; Healton CG
    Am J Prev Med; 2009 May; 36(5):385-8. PubMed ID: 19211214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review.
    Ruiz-Negrón N; Menon J; King JB; Ma J; Bellows BK
    Pharmacoeconomics; 2019 May; 37(5):669-688. PubMed ID: 30637713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The death of cost-minimization analysis?
    Briggs AH; O'Brien BJ
    Health Econ; 2001 Mar; 10(2):179-84. PubMed ID: 11252048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of cost-effectiveness and cost-usefulness in radiology].
    Janne d'Othée B; Bettmann MA; Pirard S; Zhuang Z; Black WC
    J Radiol; 2001 Dec; 82(12 Pt 1):1687-92. PubMed ID: 11917633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preference-based outcome measures in cost-utility analyses. A 20-year overview.
    Greenberg D; Pliskin JS
    Int J Technol Assess Health Care; 2002; 18(3):461-6. PubMed ID: 12391940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.